Autor: |
Rachel E. Crossland, Jean Norden, Mateja Kralj Juric, Kim F. Pearce, Clare Lendrem, Louis A. Bibby, Matthew Collin, Hildegard T. Greinix, Anne M. Dickinson |
Jazyk: |
angličtina |
Rok vydání: |
2017 |
Předmět: |
|
Zdroj: |
Frontiers in Immunology, Vol 8 (2017) |
Druh dokumentu: |
article |
ISSN: |
1664-3224 |
DOI: |
10.3389/fimmu.2017.01446 |
Popis: |
Acute graft-versus-host disease (aGvHD) is a major cause of adverse outcome in hematopoietic stem cell transplantation (HSCT), with a high incidence (20–50%). A novel, non-invasive diagnostic test to predict for prevalence and severity would enable improved prophylaxis and reduce morbidity. Circulatory microRNAs (miRNAs) miR-423, miR-199, miR-93*, and miR-377 have previously been associated with aGvHD in post-HSCT patient plasma, but validation is lacking and their expression within extracellular vesicles (EVs) has not been explored. This study replicated elevated serum expression of miR-423 (p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|